Boyer discusses a potential treatment for diabetic retinopathy and macular degeneration using suprachoroidal injections, ...

The ranibizumab ocular implant (Susvimo) reduces the need for frequent intravitreal anti-VEGF injections in patients with neovascular age-related macular degeneration or diabetic macular edema, and ...

The concern of endophthalmitis is casting a larger spector over the treatment of ocular conditions with intravitreal injection. Bevacizumab is typically obtained through such compounding ...

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with diabetic retinopathy who have previously responded to at least 2 intravitreal ...

Sunir Garg, MD, discusses a challenge in ophthalmological procedures: patient discomfort during intravitreal injections ...

W. L. Gore & Associates, Inc. ("Gore"), a global materials science company, recently announced the commercial launch of the 0 ...

Retinitis Pigmentosa therapies evolve beyond gene-specific fixes with gene-agnostic, intravitreal, and optogenetic advances ...

The new offering, designed specifically for prefilled syringes used in various applications, complements its 1 mL ImProject ...